NEW YORK, June 13, 2012 (GLOBE NEWSWIRE) -- Synergy Pharmaceuticals, Inc. (Nasdaq:SGYPD) (Nasdaq:SGYPU) (Nasdaq:SGYPW), a developer of new drugs to treat gastrointestinal disorders and diseases, today announced that its President and CEO, Gary S. Jacob, Ph.D, will present at the 2012 Biotechnology Industry Organization (BIO) Business Forum and International Convention taking place June 18-21, 2012 at the Boston Convention & Exhibition Center in Boston, MA.
